Vijay Pande on Leaving a16z’s $4B Bio Fund to Bet Small: ‘We’re Not Doing 30 Bets a Year’
Sunday, August 30, 2026 · first reported by CryptoRank
Vijay Pande departed Andreessen Horowitz's $4B Bio Fund to launch smaller, focused biotech investment vehicle.
- Fund
- Andreessen Horowitz Bio Fund
- People
- Vijay Pande
- Asset class
- Venture
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- Blackstone poaches ex-InfraBridge co-head for London infra MD roleInfrastructure Investor
- Encore Consumer Capital hires ex-Riverside principal Caroline Shettle as directorPE Hub
- Abry Partners hires Advent’s Yusef Kassim to lead investor relationsPE Hub
- Pantheon to open Abu Dhabi office, appoints Firas Mallah as head of Middle EastPE Hub +3
- VSS Capital Partners hires ex-World Bank adviser Otilia Ciotau for AI rolePE Hub
- Evolution Equity Partners Names John Cordo As Partner Following $1.1 Billion Capital RaisePulse 2.0